Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
J Biochem Mol Biol ; 37(3): 370-5, 2004 May 31.
Article in English | MEDLINE | ID: mdl-15469721

ABSTRACT

There has been increasing interest in the value of using soybean to delay or reduce the tumor incidence. This study was undertaken to investigate the possible protective effects of soybean against hepatocarcinogenesis induced by DL-ethionine. Accordingly, we measured biochemical changes occurring in serum and liver of rats treated with DL-ethionine in the presence or absence of soybean. Male albino rats were fed a control diet containing the hepatocarcinogen, DL-ethionine, or the control diet plus soybean 30%, or the control diet plus soybean plus DL-ethionine 0.25% for three months and then returned to a control diet for up to nine months. Rats fed a control diet plus DL-ethionine showed a gradual decrease in liver DNA, RNA, total protein, and liver weight and enzyme activities of liver transaminases (GOT and GPT) and alkaline phosphatase over the 7-month study period. This was followed by a large increase in the liver parameters at the end of the 9(th) month, except for 5'-nucleotidase and glucose-6-phosphatase that showed a large decrease. On the other hand, a gradual increase in the serum enzyme activities of GOT, GPT, 5-nucleotidase, alkaline phosphatase, and in the albumin/globulin (A/G) ratio is observed in the group of rats fed a control diet plus DL-ethionine compared to the control group over 8 months, and this was followed by a large increase in all serum parameters studied at nine-months. The administration of 30% soybean to the rat diet in addition to DL-ethionine maintained all parameters studied at near control values until the end of the 9(th) month. This study suggests that soybean has a protective effect against the hepatocarcinogenesis induced by DL-ethionine.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Ethionine/toxicity , Glycine max , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/drug therapy , Plant Extracts/therapeutic use , Animals , Antimetabolites/administration & dosage , Antimetabolites/toxicity , Carcinogens/administration & dosage , Carcinogens/toxicity , Diet , Ethionine/administration & dosage , Liver/pathology , Liver/physiology , Liver Neoplasms, Experimental/prevention & control , Male , Protective Agents/administration & dosage , Protective Agents/therapeutic use , Random Allocation , Rats
SELECTION OF CITATIONS
SEARCH DETAIL